These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4892624)

  • 1. Attenuated rubella vaccination in families: observations on the lack of fluorescent antibody response and on the use of blood collected on filter paper discs in the hemagglutination-inhibition test.
    Monto AS; Cavallaro JJ; Brown GC
    J Lab Clin Med; 1969 Jul; 74(1):98-102. PubMed ID: 4892624
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled family study of live, attenuated rubella-virus vaccine.
    Lefkowitz LB; Rafajko RR; Federspiel CF; Quinn RW
    N Engl J Med; 1970 Jul; 283(5):229-32. PubMed ID: 4912790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Test of anti-rubella vaccination with live and attenuated virus (Cendehill strain)].
    Leogrande G; Barnaba L; Iandolo E; Iatta E
    Minerva Med; 1970 Apr; 61(30 Suppl):1595-8. PubMed ID: 4378365
    [No Abstract]   [Full Text] [Related]  

  • 4. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with vaccination with attenuated rubella vaccine (strain HPV-77 adapted to duck cells, 5th passage)].
    Rocchi G; Salvadori A
    Nuovi Ann Ig Microbiol; 1970; 21(4):336-40. PubMed ID: 5518412
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunity and anti-rubella vaccination].
    Delville JP; Tellini-Emma M
    Arch Belg Med Soc; 1970 May; 28(5):321-30. PubMed ID: 5494764
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rubella vaccination using Cendehill's live virus vaccine].
    Vivell O; Merschmann E; Lips G; Reiss G
    Arch Kinderheilkd; 1969 Sep; 179(3):259-66. PubMed ID: 5350790
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine.
    Schmidt NJ; Lennette EH
    Am J Epidemiol; 1970 Apr; 91(4):351-4. PubMed ID: 4912184
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination with RA 27-3 rubella vaccine. Persistence of immunity and resistance to challenge after two years.
    Liebhaber H; Ingalls TH; Le Bouvier GL; Horstmann DM
    Am J Dis Child; 1972 Feb; 123(2):133-6. PubMed ID: 4554549
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on live rubella vaccine. II. Field trials with two experimental vaccine strains.
    Minekawa Y; Suzuki N; Takahashi M; Okuno Y
    Biken J; 1968 Dec; 11(4):243-50. PubMed ID: 5721530
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rubella. epidemiological studies and experiences with an attenuated vaccine ("Cendehill strain")].
    Majer R
    Helv Paediatr Acta; 1967 Dec; 22(6):579-90. PubMed ID: 4874394
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical response to immunization with Cendehill strain rubella vaccine.
    Rogers KD; Ramirez G; Cortez M; Michaels R; Savin M; Montgomery R; Welty T; Taylor F; Hingson RA
    Pediatrics; 1971 Jan; 47(1):7-15. PubMed ID: 4250964
    [No Abstract]   [Full Text] [Related]  

  • 14. "Rubella virus vaccine, live".
    Clin Pediatr (Phila); 1970 Dec; 9(12):15A passim. PubMed ID: 5487471
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trials of vaccination against rubella with the Cendehill C-51 strain of live and attenuated virus].
    Fara GM; Galli MG; Nodari R; Saccani CF; Marangoni L; Bozzetti A; Tarantino F
    Minerva Med; 1970 Apr; 61(30 Suppl):1574-7. PubMed ID: 5439721
    [No Abstract]   [Full Text] [Related]  

  • 17. [Level of antibodies against rubella in the normal population of Nanning city and a survey of the immunizing efficacy of rubella live-vaccines].
    Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb; 6(1):12-4. PubMed ID: 3995568
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemagglutinin of rubella virus: its characteristics and uses in epidemiology and clinical medicine].
    Grasso A; Gagnoni G; Cantagalli P; Dianzani F; Piazzi SE
    G Mal Infett Parassit; 1969 Jul; 21(7):603-15. PubMed ID: 5364953
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus.
    Vesikari T; Vaheri A; Leinikki P
    Arch Gesamte Virusforsch; 1971; 35(1):25-37. PubMed ID: 4943281
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of a trial of anti-rubella vaccination with vaccine made up of the "Cendehill-51" live and attenuated virus strain].
    Portolani M; Rondinini B; Brighi W; Maccolini E
    Minerva Med; 1970 Apr; 61(30 Suppl):1590-4. PubMed ID: 5439724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.